Evidence map›Paper›PMID 35907864›Full record

ArticleTrials2022

Activity tracker-based intervention to increase physical activity in patients with type 2 diabetes and healthy individuals: study protocol for a randomized controlled trial.

M Mähs, J S Pithan, I Bergmann, L Gabrys, J Graf, A Hölzemann, K Van Laerhoven, S Otto-Hagemann, M L Popescu, L Schwermann and 3 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

M MähsInstitute of Gerontology, Vechta University, Vechta, Germany. mareike.maehs@uni-vechta.de.ORCID http://orcid.org/0000-0003-2157-2887
J S PithanSport Science, Vechta University, Vechta, Germany.
I BergmannInstitute of Gerontology, Vechta University, Vechta, Germany.
L GabrysUniversity of Applied Sciences for Sport and Management Potsdam, Potsdam, Germany.
J GrafInstitute of Gerontology, Vechta University, Vechta, Germany.
A HölzemannResearch group Ubiquitous Computing, University of Siegen, Siegen, Germany.
K Van LaerhovenResearch group Ubiquitous Computing, University of Siegen, Siegen, Germany.
S Otto-HagemannDiabetologische Schwerpunktpraxis Dr. Silke Otto-Hagemann (diabetes center) Vechta, Vechta, Germany.
M L PopescuDiabetologische Schwerpunktpraxis Dr. Silke Otto-Hagemann (diabetes center) Vechta, Vechta, Germany.
L SchwermannDiabetologische Schwerpunktpraxis Dr. Silke Otto-Hagemann (diabetes center) Vechta, Vechta, Germany.
B WenzInstitute of Gerontology, Vechta University, Vechta, Germany.
I PahmeierSport Science, Vechta University, Vechta, Germany.
A TetiInstitute of Gerontology, Vechta University, Vechta, Germany.ORCID http://orcid.org/0000-0002-2112-4112
University of Vechta · DEUniversity of Siegen · DEUniversity of Applied Sciences Potsdam · DE

Funding

Niedersächsisches Ministerium für Wissenschaft und Kultur VW-ZN-3426
6 · The paper itself

Abstract

backgroundOne relevant strategy to prevent the onset and progression of type 2 diabetes mellitus (T2DM) focuses on increasing physical activity. The use of activity trackers by patients could enable objective measurement of their regular physical activity in daily life and promote physical activity through the use of a tracker-based intervention. This trial aims to answer three research questions: (1) Is the use of activity trackers suitable for longitudinal assessment of physical activity in everyday life? (2) Does the use of a tracker-based intervention lead to sustainable improvements in the physical activity of healthy individuals and in people with T2DM? (3) Does the accompanying digital motivational intervention lead to sustainable improvements in physical activity for participants using the tracker-based device?

methodsThe planned study is a randomized controlled trial focused on 1642 participants with and without T2DM for 9 months with regard to their physical activity behavior. Subjects allocated to an intervention group will wear an activity tracker. Half of the subjects in the intervention group will also receive an additional digital motivational intervention. Subjects allocated to the control group will not receive any intervention. The primary outcome is the amount of moderate and vigorous physical activity in minutes and the number of steps per week measured continuously with the activity tracker and assessed by questionnaires at four time points. Secondary endpoints are medical parameters measured at the same four time points. The collected data will be analyzed using inferential statistics and explorative data-mining techniques. DISCUSSION: The trial uses an interdisciplinary approach with a team including sports psychologists, sports scientists, health scientists, health care professionals, physicians, and computer scientists. It also involves the processing and analysis of large amounts of data collected with activity trackers. These factors represent particular strengths as well as challenges in the study.

trial registrationThe trial is registered at the World Health Organization International Clinical Trials Registry Platform via the German Clinical Studies Trial Register (DRKS), DRKS00027064 . Registered on 11 November 2021.

Indexed as

Diabetes Mellitus, Type 2Fitness TrackersExerciseHumansMotivationRandomized Controlled Trials as TopicSurveys and QuestionnairesActivity trackerDiabetesMotivation and volitionPhysical activityRandomized controlled trialWearables

Identifiers

PMID35907864
PMCPMC9338482
OpenAlexW4288748532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.